Research suggests that the null genotypes of GSTM1 and GSTT1 may elevate the risk of cervical cancer (CC) and ovarian cancer (OC) and are linked to factors associated with polycystic ovary syndrome (PCOS). The gene discussed is GSTM1; the disease is ovarian carcinoma.